RG6042
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RG6042, covering 2023-08-31 to 2023-11-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease [Phase 3]